A Less than Provocative Approach for the Primary Prevention of CAD

Area of Science:

• Cardiovascular Medicine
• Genetics
• Preventive Cardiology

Background:

• Coronary artery disease (CAD) risk correlates with low-density lipoprotein cholesterol (LDL-C) exposure duration.
• Current Cardiovascular Clinical Practice Guidelines (CCCPG) target LDL-C of 70 mg/dL, which may be insufficient for early primary prevention.
• Traditional risk factors (TRF) often manifest late, limiting their effectiveness in early CAD prevention.

Purpose of the Study:

• To evaluate the efficacy and safety of lower LDL-C targets (15-40 mg/dL) compared to current guidelines.
• To assess the superiority of genetic risk scores (GRS) over TRF for CAD risk stratification.
• To explore the potential of integrating GRS into primary prevention strategies.

Main Methods:

• Analysis of clinical trial data comparing LDL-C levels of 15-40 mg/dL versus 70 mg/dL.
• Evaluation of a large-scale study (1 million individuals) utilizing GRS for CAD risk stratification.
• Assessment of the impact of therapies (statins, PCSK9 inhibitors, lifestyle changes) on genetically predicted CAD risk.

Main Results:

• Lower LDL-C levels (15-40 mg/dL) demonstrated equal safety and greater efficacy than the CCCPG target.
• GRS proved superior to TRF in stratifying CAD risk across a large population.
• Genetic risk for CAD was significantly reduced (30-50%) by interventions, and GRS remains stable and inexpensive throughout life.

Conclusions:

• Lowering LDL-C to 15-40 mg/dL represents a more effective primary prevention strategy for CAD.
• Integrating GRS into clinical practice offers a superior, lifelong approach to CAD risk stratification.
• A paradigm shift towards genetic risk stratification in CAD primary prevention is warranted.